Use of a Hybrid Adeno-Associated Viral Vector Transposon System to Deliver the Insulin Gene to Diabetic NOD Mice

Que T. La; Binhai Ren; Grant J. Logan; Sharon C. Cunningham; Neeta Khandekar; Najah T. Nassif; Bronwyn A. O’Brien; Ian E. Alexander; Ann M. Simpson

doi:10.3390/cells9102227

Cells (Oct 2020)

Use of a Hybrid Adeno-Associated Viral Vector Transposon System to Deliver the Insulin Gene to Diabetic NOD Mice

Que T. La,
Binhai Ren,
Grant J. Logan,
Sharon C. Cunningham,
Neeta Khandekar,
Najah T. Nassif,
Bronwyn A. O’Brien,
Ian E. Alexander,
Ann M. Simpson

Affiliations

Que T. La: School of Life Sciences, University of Technology Sydney, 15 Broadway, Ultimo, NSW 2007, Australia
Binhai Ren: School of Life Sciences, University of Technology Sydney, 15 Broadway, Ultimo, NSW 2007, Australia
Grant J. Logan: Gene Therapy Research Unit, Children’s Medical Research Institute and Children’s Hospital at Westmead, Faculty of Medicine and Health, The University of Sydney and Sydney Children’s Hospitals Network, 214 Hawkesbury Rd, Westmead, NSW 2145, Australia
Sharon C. Cunningham: Gene Therapy Research Unit, Children’s Medical Research Institute and Children’s Hospital at Westmead, Faculty of Medicine and Health, The University of Sydney and Sydney Children’s Hospitals Network, 214 Hawkesbury Rd, Westmead, NSW 2145, Australia
Neeta Khandekar: Gene Therapy Research Unit, Children’s Medical Research Institute and Children’s Hospital at Westmead, Faculty of Medicine and Health, The University of Sydney and Sydney Children’s Hospitals Network, 214 Hawkesbury Rd, Westmead, NSW 2145, Australia
Najah T. Nassif: School of Life Sciences, University of Technology Sydney, 15 Broadway, Ultimo, NSW 2007, Australia
Bronwyn A. O’Brien: School of Life Sciences, University of Technology Sydney, 15 Broadway, Ultimo, NSW 2007, Australia
Ian E. Alexander: Gene Therapy Research Unit, Children’s Medical Research Institute and Children’s Hospital at Westmead, Faculty of Medicine and Health, The University of Sydney and Sydney Children’s Hospitals Network, 214 Hawkesbury Rd, Westmead, NSW 2145, Australia
Ann M. Simpson: School of Life Sciences, University of Technology Sydney, 15 Broadway, Ultimo, NSW 2007, Australia

DOI: https://doi.org/10.3390/cells9102227
Journal volume & issue: Vol. 9, no. 10
p. 2227

Abstract

Read online

Previously, we used a lentiviral vector to deliver furin-cleavable human insulin (INS-FUR) to the livers in several animal models of diabetes using intervallic infusion in full flow occlusion (FFO), with resultant reversal of diabetes, restoration of glucose tolerance and pancreatic transdifferentiation (PT), due to the expression of beta (β)-cell transcription factors (β-TFs). The present study aimed to determine whether we could similarly reverse diabetes in the non-obese diabetic (NOD) mouse using an adeno-associated viral vector (AAV) to deliver INS-FUR ± the β-TF Pdx1 to the livers of diabetic mice. The traditional AAV8, which provides episomal expression, and the hybrid AAV8/piggyBac that results in transgene integration were used. Diabetic mice that received AAV8-INS-FUR became hypoglycaemic with abnormal intraperitoneal glucose tolerance tests (IPGTTs). Expression of β-TFs was not detected in the livers. Reversal of diabetes was not achieved in mice that received AAV8-INS-FUR and AAV8-Pdx1 and IPGTTs were abnormal. Normoglycaemia and glucose tolerance were achieved in mice that received AAV8/piggyBac-INS-FUR/FFO. Definitive evidence of PT was not observed. This is the first in vivo study using the hybrid AAV8/piggyBac system to treat Type 1 diabetes (T1D). However, further development is required before the system can be used for gene therapy of T1D.

Published in Cells

ISSN: 2073-4409 (Online)
Publisher: MDPI AG
Country of publisher: Switzerland
LCC subjects: Science: Biology (General): Cytology
Website: https://www.mdpi.com/journal/cells

About the journal

Abstract

Keywords